Rhythm Pharmaceuticals Inc <RYTM.O>: J.P. Morgan initiates coverage with overweight rating; price target $145
RYTM•Related News
Satellogic names Jamil Kawar SVP, Space Systems
SATL•
Pacific Financial Corporation Announces Shareholder Approval Of Merger Agreement
PFLC•
Indonesia Energy Corporation Reports Progress On Drilling Of K-29 Well
INDO•
XTI Aerospace’s Drone Nerds partners with DBOX to distribute autonomous drone docking systems in US public safety market
XTIA•
Ovid Therapeutics releases corporate presentation outlining neural hyperexcitability drug pipeline
OVID•